Alemtuzumab (Campath-1H) in allogeneic stem cell transplantation: where do we go from here?
Alemtuzumab (Campath-1H) has been widely used for T-cell depletion following both conventional and reduced-intensity conditioning allografts. We studied the impact of alemtuzumab used in vivo and in vitro on infections, immune reconstitution, and allograft outcome. The use of alemtuzumab in vivo fol...
| Huvudupphovsmän: | , , |
|---|---|
| Materialtyp: | Journal article |
| Språk: | English |
| Publicerad: |
2004
|